| 今开：0.0 | 昨收：17.59 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：8.18469455E8 |
产业链观察02-26 21:23
#药闻简讯# $Zealand Pharma(ZEAL)$ 与 勃林格殷格翰宣布Survodutide 2 期试验显示，83% 接受治疗的成年人在 MASH 引起的肝病方面取得了突破性的结果，在纤维化方面有显着改善查看全文
$Zealand Pharma(ZEAL)$ 15F-12B Securities registration termination of foreign private issuers [Section 12(b)] Accession Number: 0001104659-22-104677 Act: 34 Size: 46 KB 网页链接
$Zealand Pharma(ZEAL)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-22-101628 Act: 33 Size: 49 KB 网页链接
$Zealand Pharma(ZEAL)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-22-101625 Act: 33 Size: 49 KB 网页链接
$Zealand Pharma(ZEAL)$ 25 Notification of the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001104659-22-101563 Act: 34 Size: 11 KB 网页链接
$Zealand Pharma(ZEAL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-22-098199 Act: 34 Size: 37 KB 网页链接
$Zealand Pharma(ZEAL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-22-096533 Act: 34 Size: 36 KB 网页链接
$Zealand Pharma(ZEAL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-22-094893 Act: 34 Size: 29 KB 网页链接
$Zealand Pharma(ZEAL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-22-088675 Act: 34 Size: 55 KB 网页链接
$Zealand Pharma(ZEAL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-22-067645 Act: 34 Size: 234 KB 网页链接
$Zealand Pharma(ZEAL)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-22-064843 Act: 33 Size: 48 MB 网页链接